Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Mladonická Pavlasová, Marek Mráz, Martin Trbušek et al.|Blood|2016Cited by 108
<i>miR-29</i> modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Marek Mráz, Gabriela Mladonická Pavlasová et al.|Blood|2021Cited by 63
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisibVeronika Šandová, Marek Mráz, Gabriela Mladonická Pavlasová et al.|Haematologica|2021Cited by 22
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemiaLaura Ondrišová, Marek Mráz, Václav Šeda et al.|Journal of Clinical Investigation|2024Cited by 12